en

PRODUCT DETAIL

Benlysta 120 mg prášok na infúzny koncentrát

Code 09504
MA number EU/1/11/700/001
Product Form: plc ifc 1x120 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA26 Belimumab
Shelf life: 60
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 13.07.2011
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Benlysta 3 4 2012.pdf  
Safety feature Yes
Data update: 15.06.2018
eu-flag.png sk-flag.png